Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Colwell: The platelet in diabetes. (0.10 sec) 

The platelet in diabetes


JA Colwell, RW Nesto - Diabetes Care, 2003 - Am Diabetes Assoc
Accelerated atherosclerosis and the increased risk of thrombotic vascular events in diabetes may
result from dyslipidemia, endothelial dysfunction, platelet hyperreactivity, an impaired
fibrinolytic balance, and abnormal ...
Cited by 129 - Related articles - BL Direct - All 5 versions

Platelet activation in type 2 diabetes mellitus


P Ferroni, S Basili, A Falco, G Davi - Journal of Thrombosis and …, 2004 - interscience.wiley.com
Summary. The abnormal metabolic state that accompanies diabetes renders arteries susceptible to
atherosclerosis, being capable of altering the functional properties of multiple cell types,
including endothelium and ...
Cited by 104 - Related articles - BL Direct - All 3 versions

Platelet dysfunction in type 2 diabetes


AI Vinik, T Erbas, TS Park, R Nolan, GL Pittenger - Diabetes Care, 2001 - Am Diabetes Assoc
Insulin resistance is a uniform finding in type 2 diabetes, as are abnormalities in the
microvascular and macrovascular circulations. These complications are associated with dysfunction of
platelets and the neurovascular ...
Cited by 254 - Related articles - BL Direct - All 5 versions

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid ( …


C Watala, J Golanski, J Pluta, M Boncler, M Rozalski, B … - Thrombosis research, 2004 - Elsevier
Aspirin (acetylsalicylic acid, ASA), which is recommended for primary and secondary prevention in
diabetes mellitus (DM), has been shown to have a lower antiplatelet activity in diabetic patients.
We conducted a crossover designed ...
Cited by 88 - Related articles - All 8 versions

Platelet function profiles in patients with type 2 diabetes and coronary artery …


DJ Angiolillo, A Fernandez-Ortiz, E Bernardo, C … - Diabetes, 2005 - Am Diabetes Assoc
To assess platelet function profiles in diabetic and nondiabetic patients on aspirin and clopidogrel
therapy, two patient populations were included to investigate the 1) acute effects of a 300-mg
clopidogrel loading dose (group 1, ...
Cited by 120 - Related articles - BL Direct - All 5 versions

Platelet hyperactivity and abnormal Ca2+ homeostasis in diabetes mellitus

- physiology.org
Y Li, V Woo, R Bose - American Journal of Physiology- Heart and …, 2001 - Am Physiological Soc
We sought to determine the mechanisms for hyperactivity and abnormal platelet Ca 2+ homeostasis in
diabetes. The glycosylated Hb (HbA 1c ) level was used as an index of glycemic control. Human
platelets were loaded with Ca- ...
Cited by 98 - Related articles - BL Direct - All 4 versions

Platelet cNOS activity is reduced in patients with IDDM and NIDDM.


V Martina, GA Bruno, F Trucco, E Zumpano, M … - Thrombosis and …, 1998 - ncbi.nlm.nih.gov
Several studies in vitro and in vivo suggest that the nitric oxide (NO) production is impaired in
diabetes mellitus. Reduced levels of NO could contribute to vascular alteration facilitating
platelet-vascular wall interaction, ...
Cited by 64 - Related articles - BL Direct - All 2 versions

Differential effect of aspirin on platelet aggregation in IDDM.


TA Mori, R Vandongen, AJ Douglas, RK McCulloch, V … - Diabetes, 1992 - Am Diabetes Assoc
Cited by 40 - Related articles - All 5 versions

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus


DL Bhatt, SP Marso, AT Hirsch, PA Ringleb, W … - The American journal of …, 2002 - Elsevier
We sought to determine whether clopidogrel compared with aspirin would be particularly efficacious
in preventing ischemic events in diabetic patients with atherosclerosis. Patients with a history of
diabetes mellitus at enrollment ...
Cited by 264 - Related articles - All 6 versions

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in …


M Sacco, F Pellegrini, MC Roncaglioni, F Avanzini, … - Diabetes Care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—The Primary Prevention Project (PPP) is a randomized, open trial with
a two-by-two factorial design aimed to investigate low-dose aspirin (100 mg/day) and vitamin E (300
mg/day) in the prevention of ...
Cited by 100 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google